- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour
Total 19566 results
-
Boehringer IngelheimCompletedNeoplasms | Breast NeoplasmsUnited States, Spain, Korea, Republic of, Finland, Japan, Denmark, France
-
MediLink Therapeutics (Suzhou) Co., Ltd.Active, not recruitingBreast Cancer | NSCLC | HNSCC | Locally Advanced or Metastatic Solid TumorsChina
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Jules Bordet InstituteAstraZeneca; Institut CurieActive, not recruiting
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
AstraZenecaActive, not recruitingMelanoma | Cervical Cancer | Small Cell Lung Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Non-Small-Cell Lung Cancer | Gastroesophageal Cancer | Clear Cell Renal Cell Cancer | Squamous Cell Cancer of Head and NeckUnited States, Spain, Canada, France
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Mural Oncology, IncActive, not recruitingAdvanced Solid TumorUnited States, Spain
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
University of BirminghamRoche Pharma AG; Cancer Research UKActive, not recruitingBreast CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Peptomyc S.L.TerminatedPancreatic Cancer | Advanced Solid Tumors | CRCSpain
-
Zealand University HospitalDanish Cancer Society; University Hospital Southampton NHS Foundation Trust; Region... and other collaboratorsActive, not recruiting
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Breast Cancer | Advanced Melanoma | Advanced Head and Neck Squamous Cell CarcinomaUnited States, France, Italy, Spain, Netherlands
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Cambridge University Hospitals NHS Foundation TrustBoehringer Ingelheim; Cancer Research UK; University of Cambridge; The Brain Tumour...TerminatedBreast Cancer | Advanced Breast Cancer | Lung Cancer | Brain Cancer | Advanced Lung CancerUnited Kingdom
-
Cellestia Biotech AGTerminatedBreast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALLUnited States, Spain, Korea, Republic of, Germany, France, Switzerland
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
Fusion Pharmaceuticals Inc.TerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations | FGFR3 | FGFR3 Overexpression | FGFR3 Receptor | FGFR3 Protein OverexpressionUnited States, Australia
-
Hospital Sirio-LibanesActive, not recruitingBreast Cancer | AnesthesiaBrazil
-
Robert WesolowskiCompletedBreast Cancer | Ovarian Cancer | Malignant Solid Tumour | GIST | Malignant Tumor of ColonUnited States
-
Ontario Clinical Oncology Group (OCOG)British Columbia Cancer AgencyActive, not recruiting
-
Institut Claudius RegaudActive, not recruitingTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
AstraZenecaCompletedOvarian Cancer, TNBC, SCLC, Other Solid TumoursUnited States, Canada
-
Eisai LimitedCompletedOvarian Cancer | Triple Negative Breast Cancer | Malignant Solid Tumour | Advanced Melanoma | B-cell Malignancy, Low-gradeUnited Kingdom
-
Trans Tasman Radiation Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaboratorsActive, not recruitingCarcinoma, Ductal, BreastUnited Kingdom, Netherlands, Ireland, Switzerland, Australia, Singapore, New Zealand, Belgium, Canada, Italy, France
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Institut BergoniéNational Cancer Institute, France; Institut du Cancer de Montpellier - Val... and other collaboratorsActive, not recruiting
-
SOLTI Breast Cancer Research GroupNovartis; Roche Pharma AG; Guardant Health, Inc.Active, not recruitingMetastatic Breast CancerSpain
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Imperial College London4D pharma plcActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Urethral Cancer | Uterine CancerUnited Kingdom
-
Istanbul Training and Research HospitalCompletedBreast CancerTurkey
-
Presage BiosciencesTakedaWithdrawn
-
Philogen S.p.A.CompletedAdvanced Solid Tumors Amenable to Anthracycline Therapy | Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline TherapyGermany, Italy
-
Imperial College LondonCancer Research UK; Waters CorporationCompletedBreast Cancer | SurgeryUnited Kingdom
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
iOMEDICO AGArbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienCompletedBreast Cancer
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; National Institute for Health Research Biomedical...Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
University of ValenciaCompletedPostoperative Pain | Chronic Post Operative Pain | Breast Tumor | Locoregional Anesthesia | Breast PainSpain
-
National University Health System, SingaporeCompletedFollicular Thyroid CancerSingapore
-
NHS TaysideCompleted
-
Universität Duisburg-EssenKarl and Veronica Carstens FoundationCompletedBreast NeoplasmGermany
-
Texas Tech University Health Sciences Center, El...SuspendedMetastatic Triple-Negative Breast CancerUnited States
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid TumoursChina
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
Peking Union Medical College HospitalXi'an Central Hospital; Fudan University; Shanghai Zhongshan Hospital; Peking University... and other collaboratorsCompleted